InsidersTradesSigma
Follow the 이뮨온시아 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 이뮨온시아 has logged 8 insider filings. Market capitalisation: €248bn. The latest transaction was reported on 28 May 2026 (Purchase). Among the most active insiders: 유한양행. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
이뮨온시아 是一家在XKRX市场上市的医疗保健和制药公司。它专注于开发自身免疫疾病的创新疗法。